✦ LIBER ✦

A randomized trial comparing ursodeoxycholic acid and rofecoxib, a selective Cox-2 inhibitor, in the treatment of advanced duodenal adenomas in patients with familial adenomatous polyposis

✍ Scribed by Maclean, Anthony R.; McLeod, Robin S.; Berk, Terri; Gallinger, Steven

Book ID: 124103522
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 185 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)81255-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid counteracts celecox

Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial

✍ van Heumen, Bjorn WH; Roelofs, Hennie MJ; Vink-Börger, M; Dekker, Evelien; Mathu 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 353 KB

The effect of ursodesoxycholic acid on d

The effect of ursodesoxycholic acid on duodenal adenomas in familial adenomatous polyposis: a prospective randomized placebo-control trial

✍ Y. Parc; B. Desaint; J.-F. Fléjou; J. H. Lefèvre; L. Serfaty; A. Vienne; S. Kott 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Does a selective cyclooxygenase-2 inhibi

Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial

✍ Takeo Iwama; Takayuki Akasu; Joji Utsunomiya; Tetsuichiro Muto 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 272 KB

M1942 A Double Bind Placebo Controlled A

M1942 A Double Bind Placebo Controlled Assessment of Mucosal Changes of the Duodenum in Patients with Familial Adenomatous Polyposis (FAP) After Treatment with a COX-2 Inhibitor (Rofecoxib)

✍ Aabakken, Lars; Fausa, Olav; Pascual, Ana Lobato; Schjolberg, Aasa; Andresen, Pe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Randomized controlled trial of the effec

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis

✍ K. P. Nugent; K. C. R. Farmer; A. D. Spigelman; C. B. Williams; Mr R. K. S. Phil 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views